Home / Companies / Viridian Therapeutics, Inc. / 17 Jun 2024
Viridian Therapeutics, Inc.: meeting of 17 Jun 2024
Votes reported on Form N-PX, item by item
237 Form N-PX filers reported votes at the Viridian Therapeutics, Inc. meeting of 17 Jun 2024. Their records fall into 4 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.
foragainstabstain, withhold or otheramber tick: the portion cast against management
Items
DIRECTOR ELECTIONSIssuer
Director elections
2 nominees; 69.9% of reported votes for; 61 filers withheld from or voted against at least one nominee.
315 vote records from 86 filers. 1 of the 86 filers that marked the item either way voted against management.
SECTION 14A SAY-ON-PAY VOTESIssuer
Advisory vote on executive pay (say-on-pay)
356 vote records from 237 filers. 157 of the 229 filers that marked the item either way voted against management. 8 filers reported this item without a management mark.
AUDIT-RELATEDIssuer
Audit-related items (auditor ratification)
158 vote records from 86 filers. 1 of the 86 filers that marked the item either way voted against management.
COMPENSATIONIssuer
COMPENSATION: management items
Management items in this category are shown together; filers word and number them differently.
157 vote records from 85 filers. 53 of the 85 filers that marked the item either way voted against management.
How the largest families voted
| Family | 1. Directors | 2. Say-on-pay | 3. Auditor |
|---|---|---|---|
| Vanguard | For | For | For |
| BlackRock and iShares | For | Against * | For |
| Fidelity | For | Against * | For |
| Dimensional | Split or no vote | Against * | For |
| State Street and SPDR | For | For | For |
| Invesco | No report | Against * | No report |
| Equitable | For | Against * | For |
| Charles Schwab | Split or no vote | Against * | For |
| Nuveen and TIAA | For | For | For |
| ProShares and ProFunds | Split or no vote | Against * | For |
| John Hancock and Manulife | Split or no vote | Against * | For |
| Morgan Stanley, Eaton Vance and Calvert | For | Against * | For |
| J.P. Morgan | For | For | For |
| Goldman Sachs | Split or no vote | Against * | For |
| PGIM and Prudential | No report | Against * | No report |
| Northern Trust and FlexShares | For | For | For |
| SEI | Split or no vote | Against * | For |
| T. Rowe Price | Split or no vote | Against * | For |
| Lincoln Financial | Split or no vote | For | For |
| Voya | Split or no vote | For | For |
| Russell Investments | Split or no vote | Against * | For |
| Nationwide | Split or no vote | Against * | For |
| Victory Capital | Split or no vote | Against * | For |
| Brighthouse Funds | Split or no vote | Against * | For |
| Guggenheim and Rydex | Split or no vote | Against * | For |
| Columbia Threadneedle | No report | Against * | No report |
| BNY Mellon | No report | Against * | No report |
| Principal | Split or no vote | Against * | For |
| Pacific Life funds | For | Against * | For |
| Global X | Split or no vote | Against * | For |
| AllianceBernstein | Split or no vote | Against * | For |
| DWS | Split or no vote | Against * | For |
| Janus Henderson | No report | Against * | No report |
| Neuberger Berman | No report | Against * | No report |
| Natixis and Loomis Sayles | No report | Against * | No report |
* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.
Questions
How did large funds vote at the Viridian Therapeutics, Inc. meeting?
237 Form N-PX filers reported votes at the meeting of 17 Jun 2024. On say-on-pay, 157 of 229 voted against management (68.6%). The family table lists each of the largest families item by item.
Is this the meeting result?
No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Viridian Therapeutics, Inc. on Form 8-K.
Why are director elections shown as counts only?
Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.
Every meeting on file for Viridian Therapeutics, Inc.
Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Viridian Therapeutics, Inc. with a meeting date within three days of 17 Jun 2024. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.